Breast Cancer Clinical Trial

Choose to Lose for Women-Weight Loss to Reduce Breast Cancer Risk Factors

Summary

This study is investigating the changes in specific hormone levels in women age 30-45 after a 12 week weight loss intervention.

View Full Description

Full Description

In sum, excess body weight and inactivity have emerged as strong avoidable causes of postmenopausal breast cancer, with the greatest potential for primary prevention occurring during the premenopausal years. However, surprisingly, no study to date has examined the effects of a standard behavioral weight loss intervention on breast cancer risk markers in premenopausal women. Understanding the effects of weight loss in premenopausal women is a critical next step in existing research and will inform the development of future breast cancer primary prevention programs. The purpose of this study is to determine the feasibility of recruiting, treating, and retaining 20 overweight/obese women in a 12-week randomized control trial examining feasibility and effects of a behavioral weight loss program on breast cancer risk markers in premenopausal women. Participants will be randomly assigned to either a 12-week comprehensive behavioral weight loss program (n=10) or control condition (n=10). All women will be assessed at baseline and after 3 months of treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Premenopausal women
Age 30-45
Current BMI of >25
English or Spanish speaking
5th grade reading level
Menstrual regularity, defined as menstrual cycle length of 27-31 and < 1 missed period within the past 12 months.

Exclusion Criteria:

Current use or recent (< 6 months) use of oral contraceptives, hormones, or other hormone-influencing medications
Pregnant, lactating or planning pregnancy in the next 12 weeks
Unwilling and able to location for intervention visits.
Serious medical condition requiring the supervision of a physician for exercise and diet
History of eating disorder
History of or current use of drugs
Current treatment for serious psychological disorder
Donation of blood within past 6 weeks.

Study is for people with:

Breast Cancer

Phase:

Early Phase 1

Estimated Enrollment:

19

Study ID:

NCT01096901

Recruitment Status:

Completed

Sponsor:

California Polytechnic State University-San Luis Obispo

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

California Polytechnic State University
San Luis Obispo California, 93407, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Early Phase 1

Estimated Enrollment:

19

Study ID:

NCT01096901

Recruitment Status:

Completed

Sponsor:


California Polytechnic State University-San Luis Obispo

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider